Home › Metastatic Cancer › Illinois › Bloomington
Metastatic Cancer clinical trials in Bloomington, IL
3 studies for Metastatic Cancer are looking for participants at sites in and around Bloomington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RecruitingPhase 2
- Illinois CancerCare-Bloomington, Bloomington
- Carle BroMenn Medical Center, Normal · 2 mi away
- Carle Cancer Institute Normal, Normal · 2 mi away
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RecruitingPhase 3
- Illinois CancerCare - Bloomington, Bloomington
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
RecruitingPhase 3
- Illinois CancerCare - Bloomington, Bloomington
Metastatic Cancer trials in other cities
- Houston, TX100 studies
- New York City, NY93 studies
- Nashville, TN69 studies
- Boston, MA61 studies
- Los Angeles, CA57 studies
- Arlington, VA52 studies
- St. Louis, MO52 studies
- San Antonio, TX44 studies
- Washington, DC44 studies
- Dallas, TX44 studies
- Philadelphia, PA42 studies
- Chicago, IL42 studies
Other studies in Bloomington
- Non-Small Cell Lung Cancer12 studies
- Lung Cancer10 studies
- Prostate Cancer7 studies
- Colorectal Cancer7 studies
- Breast Cancer5 studies
- Melanoma5 studies
- Pancreatic Cancer5 studies
- Head and Neck Squamous Cell Carcinoma5 studies
- Bladder Cancer4 studies
- Kidney Cancer (Renal Cell Carcinoma)4 studies
- Acute Myeloid Leukemia4 studies
- Colon Cancer4 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.